4P-Pharma is a clinical-stage biotech company that focuses on developing innovative therapies for serious diseases with significant unmet medical needs. Established in 2014, the company employs a specialized research and development (R&D) engine that enhances risk management and accelerates the drug development process. This approach aims to reduce time, costs, and uncertainty associated with bringing first-in-class therapies to market. 4P-Pharma utilizes cutting-edge clinical trial designs and expedited regulatory pathways to ensure that their therapies reach patients as quickly as possible. Their business model emphasizes patient-centered drug development, integrating real-world insights and challenges into the therapeutic process.

The company actively engages in open innovation by collaborating with leading academic institutions and AI technology organizations to source and develop therapeutic candidates. Their internal capabilities include leveraging in-house contract research organization (CRO) expertise for thorough preclinical development. 4P-Pharma's pipeline encompasses a wide range of therapeutic areas, including chronic and autoimmune diseases, respiratory and infectious diseases, and ophthalmological conditions. Notable projects include 4P004, a potential first-in-class drug for osteoarthritis, and partnerships with AI tech companies like Oncocross and Delta4 to develop treatments for systemic sclerosis and primary sclerosing cholangitis, respectively. Through these initiatives, 4P-Pharma aims to transform scientific knowledge into impactful drug success stories.

France

Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly.​

Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty.​

We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible.

4P-Pharma

Company Details